Bio Pharma Dive
FEBRUARY 4, 2021
With J&J's application filed, the FDA will start reviewing study results which the company says show its shot to be 66% effective against moderate or severe COVID-19.
World of DTC Marketing
FEBRUARY 4, 2021
SUMMARY: The industry is facing several challenges on several fronts. Amgen is laying off people because of their poor financial outlook. Merck’s old drugs are under more scrutiny, and anti-vaxxers are causing problems by cherry-picking unreliable information. Amgen announced that it’s laying off a significant number of people, most from the salesforce, under the guise that they’re going “digital.” Let’s be honest: this is a way to inflate a company’s st
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
FEBRUARY 4, 2021
Frazier, who's retiring after a three-decade career at Merck, will hand the reins to CFO Robert Davis at the end of June. While Frazier's tenure was framed by the success of Keytruda, his leadership extended far beyond Merck's walls.
Pharma Mirror
FEBRUARY 4, 2021
Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has been selected(1) by Japan’s Ministry of Health, Labour and Welfare (MHLW) to implement the Japan-Russia Medical Cooperation Promotion Project in the field of endoscopy for the fiscal year ending March, 2021. Under the project, Olympus will promulgate gastrointestinal endoscopic/laparoscopic techniques in support of a five-year oncology plan launched by the Russian
Bio Pharma Dive
FEBRUARY 4, 2021
The government-funded trial will evaluate the effects of mixing vaccines and varying timing between shots.
Pharma Mirror
FEBRUARY 4, 2021
The American Dream is why the United States is considered the “land of opportunity,” and why for centuries immigrants have flocked to our shores seeking their fortunes. Guo-Liang Yu, Ph.D., (China), and Sanjeev Redkar, Ph.D., (India), came to the U.S. in the 1980s. By anyone’s reasonable measure, both have achieved the American Dream.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Mirror
FEBRUARY 4, 2021
Ensuring punches and dies are kept in optimum condition is essential to produce high quality tablets. As the demand for pharmaceutical tablets increases, the importance for proficient tool maintenance becomes even more important. To help companies understand the processes involved, I Holland, leaders in the manufacture of tablet tooling, will launch a free seven month webinar series, with the first presentation taking place at 2pm GMT on 25th February 2021.
pharmaphorum
FEBRUARY 4, 2021
For World Cancer Day, David Long, business unit director of Oncology at MSD UK tells pharmaphorum about the company’s ‘Do It Yourself’ campaign launched in the North East to raise awareness of lung cancer symptoms. As COVID cases surged last year, lung cancer referrals dropped in the UK, causing alarm to the UK Lung Cancer Coalition (UKLCC), an alliance of the UK’s leading lung cancer experts, senior NHS professionals, charities, and healthcare companies.
Pharma Mirror
FEBRUARY 4, 2021
Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has been selected(1) by Japan’s Ministry of Health, Labour and Welfare (MHLW) to implement the Japan-Russia Medical Cooperation Promotion Project in the field of endoscopy for the fiscal year ending March, 2021. Under the project, Olympus will promulgate gastrointestinal endoscopic/laparoscopic techniques in support of a five-year oncology plan launched by the Russian
Outsourcing Pharma
FEBRUARY 4, 2021
The founder of Andaman7âs leukemia diagnosis, and his sonâs experience with bone cancer, have helped inform the firm's tech and patient-centric approach.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
FEBRUARY 4, 2021
By Jennifer Mercer , CEO of Metazoa. Jennifer Mercer is Co-founder and CEO of Metazoa, developers of Snapshot, an admin and developer tool for companies with complex Salesforce orgs that is used by over 60% of Fortune 100 companies. . Salesforce org management is usually not the headliner for CIOs and CTOs looking to catch up on executive-level trends and issues pertaining to technology.
BioSpace
FEBRUARY 4, 2021
A new study report in Science suggests SARS-CoV-2 and its mutated new variants can evade immune responses via the selective deletion of small sections of the virus’s genetic sequence.
BioPharma Reporter
FEBRUARY 4, 2021
An Oxford University trial, a world first, is looking at whether inoculating volunteers with doses of different combinations of two currently approved COVID-19 vaccines is effective.
BioSpace
FEBRUARY 4, 2021
The Swiss health authority Swissmedic rejected AstraZeneca’s rolling authorization application for its COVID-19 vaccine a few days ago, saying more data is needed “to obtain more information about safety, efficacy, and quality.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
FEBRUARY 4, 2021
Super Bowl LV will be played on February 7, 2021 at the Raymond James Stadium in Tampa, Florida where the Kansas City Chiefs and the Tampa Bay Buccaneers will compete to win the 55 th Super Bowl. The Super Bowl is watched by 102 million people, and the advertisements are just as highly anticipated as the outcome of the game itself. A Super Bowl commercial in 2019 cost between $5.1 and $5.3 million for a 30-second slot, according to Bloomberg.
BioPharma Reporter
FEBRUARY 4, 2021
Illumina, a DNA sequencing and array-based technology specialist, is supporting the Belgian Society of Medical Oncology (BSMO) in a pilot study examining the use of comprehensive genomic profiling (CGP) in 864 patients with advanced metastatic cancer.
Pharma Marketing Network
FEBRUARY 4, 2021
Moderator and Panelists: Amy Turnquist , EVP, Digital, eHealthcare Solutions (Moderator). Ryan Billings , U.S. Oncology Digital Marketing & Customer Experience at GSK. Desiree Priestley , Director, Patient Support Strategy & Insights at Otsuka America Pharmaceutical. Kristen Palmer Winters , Customer Experience (CX), Americas Hub, Digital & Commercial Innovation, Bayer.
BioSpace
FEBRUARY 4, 2021
Over the course of 2020, Sanofi saw significant growth in its specialty care sales primarily driven by its blue-chip asset, Dupixent, as well as an increase in vaccine sales that were driven by demand for differentiated influenza vaccines, the company announced in its year-end financial report.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
FEBRUARY 4, 2021
Credit: Denis Kosyanov, FEFU PI REC for Advanced Ceramic Materials Research Scientists of Far Eastern Federal University (FEFU) have advanced the technology of high-speed sintering for optical ceramics (Nd3+:YAG), i.e. active elements generating laser emission in the near-infrared wavelength range (1.06 ?m) for cutting the edge microelectronics and medicine.
Outsourcing Pharma
FEBRUARY 4, 2021
A report from the World Economic Forum and Lung Ambition Alliance outlines the impacts the pandemic is having on lung cancer diagnoses and treatment.
Scienmag
FEBRUARY 4, 2021
Credit: G. Milisenda and coathors A new study in Frontiers in Marine Science provides a first-of-its-kind evaluation of which regions of southern European seas are in the most need of fishing restrictions. These areas have persistently shown high numbers of undersized fish and crustaceans, which are typically discarded because they are below the allowable size […].
BioPharma Reporter
FEBRUARY 4, 2021
New Zealandâs regulator Medsafe has given the Pfizer/BioNTech vaccine provisional approval, with border workers the first to be offered the vaccine.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
FEBRUARY 4, 2021
Study has big implications for management of bat populations Credit: Sarah Gignoux-Wolfsohn Scientists have found genetic differences between bats killed by white-nose syndrome and bats that survived, suggesting that survivors rapidly evolve to resist the fungal disease, according to a Rutgers-led study with big implications for deciding how to safeguard bat populations.
Pharma Times
FEBRUARY 4, 2021
Projects will investigate immune checkpoints and contribute to the development of new cancer treatments
Scienmag
FEBRUARY 4, 2021
Credit: Lewis, D. H., D. E. Jarvis, and P. J. Maughan. 2020. SSRgenotyper: A simple sequence repeat genotyping application for whole-genome resequencing and reduced representational sequencing projects. Applications in Plant Sciences… SSRgenotyper is a newly developed, free bioinformatic tool that allows researchers to digitally genotype sequenced populations using simple sequence repeats (SSRs), a task that […].
Outsourcing Pharma
FEBRUARY 4, 2021
William Gholston, with the Tampa Bay Buccaneers football team, is donating to the Moffitt Cancer Center to fund research into cancer treatment disparities.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
FEBRUARY 4, 2021
Credit: @Science China Press The rapid development of silicon-based transistors leads to its integration getting closer to the limit of Moore’s law. Graphene is expected to become the next generation of mainstream chip materials due to its ultra-high carrier mobility. However, it is difficult to obtain a high on/off current ratio for intrinsic graphene-based transistor […].
BioSpace
FEBRUARY 4, 2021
Less than one week after posting a positive first-look at Phase III vaccine data, Maryland-based Novavax began the rolling review process for authorization of NVX-CoV2373 in the United Kingdom, Canada and the United States.
Scienmag
FEBRUARY 4, 2021
The study will leverage genomics and digital technologies to better understand factors that contribute to obesity and type 2 diabetes LA JOLLA, CA–Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses […].
BioSpace
FEBRUARY 4, 2021
Foster City-based Gilead Sciences says its inhaled version of remdesivir, which has been increasingly used in research and practice to combat COVID-19 in hospitalized patients, won’t be available any time soon as it needs more testing in clinical research.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
317 
Let's personalize your content